Syneron Medical Ltd

Available to platforms
R StocksTrader

Syneron Medical Ltd (ELOS.nq) on the NASDAQ Exchange

Company overview

Syneron Medical Ltd is a publicly listed company from USA with shares traded on NASDAQ under the ticker ELOS.nq. This page provides a live view of market pricing and an interactive chart to follow short and long-term moves without manual refresh. The latest streaming quotes for ELOS.nq are bid 10.95 USD and ask 11 USD.

Use the chart to review recent momentum, identify key price areas, and track how Syneron Medical Ltd is performing relative to your portfolio in 2025. If you are researching the instrument for trading or investing, add ELOS.nq to your watchlist in R StocksTrader and compare it with other US and European shares, indices, and metals.

Key facts

  • Exchange: NASDAQ
  • Company: Syneron Medical Ltd
  • Ticker: ELOS.nq
  • Country: USA
  • Bid10.95 USD
  • Ask11 USD
  • Quotes: real-time, auto-updated

Risk

Risk Warning: Past performance of ELOS.nq does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy, and then place an order for Syneron Medical Ltd (ELOS.nq) in R StocksTrader. Create and verify your profile, fund the account, search for ELOS.nq, and choose the instrument type available to you. Add ELOS.nq to your Watchlist to track moves and manage open positions throughout 2025.

ELOS.nq trades on NASDAQ and is issued by Syneron Medical Ltd. This page provides a live chart and continuously updated price data for the 2025 year so that you can follow intraday swings and longer trends. Before starting trading and placing orders, review trading hours, typical spreads, and fees in the terminal to make sure conditions for ELOS.nq match your plan.

Quotes update automatically in real time. Current levels for ELOS.nq are bid 10.95 USD and ask 11 USD. The spread is the difference between ask and bid and affects your effective entry and exit. Track ELOS.nq in R StocksTrader and adjust your approach as market conditions change in 2025.